Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando A Atik

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Journal of Cardiac Failure|December 13, 2022
Extracorporeal Membrane Oxygenation for Graft Dysfunction Early After Heart Transplantation: A Systematic Review and Meta-analysisNatasha Aleksova, Tayler A Buchan, Farid Foroutan, et al.
The New England Journal of Medicine|November 16, 2020
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral ValveHelio P Guimarães, Renato D Lopes, Pedro G M de Barros E Silva, et al.
American Heart Journal|October 12, 2020
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trialHelio P Guimarães, Pedro G M de Barros E Silva, Idelzuita L Liporace, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Journal of Cardiac Failure|December 13, 2022
Extracorporeal Membrane Oxygenation for Graft Dysfunction Early After Heart Transplantation: A Systematic Review and Meta-analysisNatasha Aleksova, Tayler A Buchan, Farid Foroutan, et al.
The New England Journal of Medicine|November 16, 2020
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral ValveHelio P Guimarães, Renato D Lopes, Pedro G M de Barros E Silva, et al.
American Heart Journal|October 12, 2020
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trialHelio P Guimarães, Pedro G M de Barros E Silva, Idelzuita L Liporace, et al.
Pageof 6